RA
Richard Aldrich
Director

Richard Aldrich insider trades: Concert Pharmaceuticals (CNCE) stock buys and sales

Director, Concert Pharmaceuticals Last trade Jun 6, 2022 130 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
82
Open-market trades
since 2006
13
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Richard reports to the SEC

and 7 more companies

Open-market buys and sales

82 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 6, 2022CNCE↑ Buy$1000K
Nov 15, 2018CNCE↑ Buy$591K
Feb 1, 2018CNCE↓ Sell$250K
Jan 29, 2018CNCE↓ Sell$372K
Jan 24, 2018CNCE↓ Sell$591K
Jan 19, 2018CNCE↓ Sell$580K
Jan 16, 2018CNCE↓ Sell$405K
Jan 16, 2018CNCE↓ Sell$193K
Oct 12, 2017KALV↑ Buy$4.9M
Jun 1, 2016OVAS↑ Buy$3.0M
May 18, 2016OVAS↑ Buy$157K
May 17, 2016OVAS↑ Buy$305K
May 13, 2016OVAS↑ Buy$250K
May 11, 2016OVAS↑ Buy$153K
May 10, 2016OVAS↑ Buy$154K
Mar 24, 2016OVAS↑ Buy$567K
Mar 22, 2016OVAS↑ Buy$625K
Mar 18, 2016OVAS↑ Buy$493K
Mar 16, 2016OVAS↑ Buy$466K
Mar 14, 2016OVAS↑ Buy$1.2M
Dec 16, 2015CNCE↓ Sell$395K
Jun 8, 2015PTCT↓ Sell$390K
Apr 8, 2015OVAS↑ Buy$75K
Jul 7, 2014OVAS↑ Buy$19K
Jun 30, 2014OVAS↑ Buy$18K
Jun 23, 2014OVAS↑ Buy$18K
Jun 16, 2014OVAS↑ Buy$17K
Jun 9, 2014OVAS↑ Buy$15K
Jun 2, 2014OVAS↑ Buy$15K
May 27, 2014OVAS↑ Buy$15K
May 20, 2014VSTM↑ Buy$8K
May 19, 2014OVAS↑ Buy$15K
Mar 7, 2014OVAS↑ Buy$1.0M
Nov 11, 2013VSTM↑ Buy$11K
Nov 4, 2013VSTM↑ Buy$11K
Oct 28, 2013VSTM↑ Buy$11K
Oct 21, 2013VSTM↑ Buy$13K
Oct 14, 2013VSTM↑ Buy$11K
Oct 7, 2013VSTM↑ Buy$12K
Sep 30, 2013VSTM↑ Buy$13K
Sep 23, 2013VSTM↑ Buy$13K
Sep 16, 2013VSTM↑ Buy$14K
Sep 11, 2013OVAS↑ Buy$51K
Sep 9, 2013VSTM↑ Buy$14K
Sep 3, 2013VSTM↑ Buy$14K
Aug 26, 2013VSTM↑ Buy$14K
Aug 19, 2013VSTM↑ Buy$13K
Aug 12, 2013VSTM↑ Buy$15K
Aug 5, 2013VSTM↑ Buy$15K
Jul 29, 2013VSTM↑ Buy$15K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Richard Aldrich's insider trades

Richard Aldrich is a director at Concert Pharmaceuticals (CNCE). Since Dec 21, 2006, Richard has reported 70 open-market purchases worth $45.0M and 12 sales worth $6.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (42 filings), conversions (5 filings), other transactions (4 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.